RNTX

Rein Therapeutics Inc.

Insider Trades

NameValueActionPriceCurrent Price
Von Rickenbach Josef HDirector
$4.8k4.5k shares
BuyMay 27, 2026
$1.07
--
Von Rickenbach Josef HDirector
$24k23.2k shares
BuyMay 26, 2026
$1.06
--
Von Rickenbach Josef HDirector
$17k16k shares
BuyMay 22, 2026
$1.05
--
Von Rickenbach Josef HDirector
$3.6k3.4k shares
BuyMay 21, 2026
$1.04
--
Windsor James BrianDirector, Officer: See Remarks
$25k25k shares
BuyApr 30, 2026
$1.00
--
Voss Capital, LP10 Percent Owner
$128k104.2k shares
BuyNov 14, 2025
$1.22
--

News

globenewswire.comRein Therapeutics Expands Phase 2 RENEW Trial into United Kingdomglobenewswire.comJun 11globenewswire.comRein Therapeutics Announces Closing of $57.5 Million Underwritten Public Offering, Including Full Exercise of Over-Allotment Optionglobenewswire.comMay 18globenewswire.comRein Therapeutics Announces Pricing of $50 Million Underwritten Public Offering of Common Stockglobenewswire.comApr 30globenewswire.comRein Therapeutics Provides Clinical Trial Update for Phase 2 RENEW Study of LTI-03 in Idiopathic Pulmonary Fibrosisglobenewswire.comApr 29defenseworld.netRein Therapeutics (NASDAQ:RNTX) Stock Price Up 1.6% – What’s Next?defenseworld.netMar 14